Migraine Pathophysiology. Robert E. Shapiro, MD, PhD
|
|
- Aldous Flowers
- 5 years ago
- Views:
Transcription
1 Migraine Pathophysiology Robert E. Shapiro, MD, PhD
2 Disclosures Eli Lilly Member, Clinical Trials Data Monitoring Committee
3 Learning Objectives By the end of this course participants will be able to describe: the role of cortical spreading depression in migraine aura. the role of the trigeminovascular system in migraine headache the current state of genetic findings for migraine susceptibility. the current state of neuroimaging for migraine.
4 Migraine is NOT Headache Migraine is an episodic state of the nervous system. Headache is one, among many, potential symptoms of the migraine state. migraine symptom patterns idiosyncratic stereotypic evolving migraine susceptibility heritable 50% expressivity chronobiologic hormonal, diurnal, circadian, etc. stimulus-bound chemical, weather, stress
5 Migraine Attacks Premonitory phase: ~ one third of patients, ~ hours to days Aura phase: (~ 25 % of patients): < 60 min symptoms: visual, paresthesias, cognitive, behavioral, perceptual sensory > motor, positive > negative, dynamic > static Headache phase: pain: sensitivities: autonomic: ~4 hours to 3 days unilateral, throbbing, moderate to severe light, sound, odor, touch (allodynia), movement (vertigo) nausea (~90%), vomiting, gastric atony, sinus congestion Recovery phase
6 Phases of a Migraine Attack Mild Moderate to Severe Premonitory/ Prodrome Aura Headache Postdrome Time Adapted from Cady RK. Clin Cornerstone;1: (1999) & Blau JN Lancet; 339:1203 (1992)
7 Probability of Phosphene Magnetic Stimulus Intensity (%) Aurora SK et al. Cephalalgia. 2003;23: The visual cortex of migraineurs is intrinsically hyperexcitable
8 Chronobiology of Migraine 18 seconds 1 day 1 week 1 month 1 year 2 years Lifetime Fox and Davis, Headache 38: 436 (1998) Cugini Chronobiol Internat. 7:467 (1990). Victor et al. Cephalalgia 30:1065 (2010) Mo et al Pain 2013;154:1150 Lipton et al 2014 AHS
9 fmri of Spontaneous Migraine Roles of Left-Pain Right-Pain Hypothalamus Dorsal Pons Occipital Cortex Trigeminal Nucleus N. Tractus Solitarius Weiller et al Nature Med 1:658 (1995) Afridi et al. Brain 128:932 (2005) Schulte & May, Brain 139:1987 (2016) Maniyar et al Headache 55:609 (2015)
10 Stimulus-induced fmri: ictal vs interictal migraineurs No areas have less activity during a migraine attack than in the interictal period. Schewdt et al Lancet Neurol 2015; 14: 81
11 What Causes Aura in Migraine? Sacks Migraine rev. ed. (1999)
12 Migraine Aura and Spreading Depression Lashley s aura (194I) Inferred propagation: 2 4 mm / min Leão s Spreading Depression (1944) Observed Propagation: 2 4 mm / min Human Perception Rabbit Cortex Lashley Arch Neurol Psych 46:333 (1941) Leao J Neurophysiol 7:359 (1944) Silberstein et al. Headache in Clinical Practice 2 nd ed. (2002)
13 Cortical Spreading Depression Spreading Depression? Massive wave of depolarization, propagating at 2 to 4 mm/min, followed by suppressed cortical activity Fluxes in extracellular glutamate and K + Blood oxygenation level-dependent (BOLD) functional MR imaging Hadjikhani et al. PNAS. 98:4687 (2001) Changes in vascular tone
14 The Search for Migraine Genes Louis Ptáček
15 Search for Migraine Genes Twins studies: 30 to 60% heritable Tolner et al, Pain 156:S64 S74 (2015)
16 Search for Migraine Genes Tolner et al, Pain 156:S64 S74 (2015)
17 Channels Implicated in Migraine Voltage-gated C ++ Channel CACNL14 FHM1 Voltage-gated Na + Channel SCN1A FHM3 Na + /K + ATPase Pump ATP1A2 - FHM2 Glutamate Transporter SLC1A3 Episodic Ataxia type 6 Voltage-gated Two-Pore Domain K + Channel TRESK K2P channel Na + /HCO 3- Co-transporter NBCe1 glaucoma, RTA Connexin CX43 CK1δ FASPS? Pannexin Panx1? None of these genotypes have been associated with prevalent forms of migraine
18 FHM1 Mutation Promotes CSD Increased CSD Propagation Velocity Lowered CSD Triggering Threshold van den Maagdenberg et al, Neuron 41: (2004)
19 FHM Mutation Functional Convergence Loss of Function: Na + /K + transport Loss of Function: Na + channel recovery Gain of Function: Ca ++ influx NMDA Modified from Ferrari et al Lancet Neurol 2015;14:65 EA-6 Loss of Function: glutamate transport
20 FHM Mutation Functional Convergence EA-6 SLC1A3 EAAT1 glutamate transporter Modified from van der Ven et al, Arch Neurol 64:643 (2007)
21 What Causes Headache in Migraine? Anguish - George Dergalis
22 Wolff s Observations Only some Intracranial structures Are pain sensitive: Some regions of Dura mater Meningeal vessels, large cerebral vessels & sinuses Muscles of scalp, head and neck Nerves: 5 th, 7 th, 9 th, 10 th, C1, C2 Wolff Headache 1 st ed (1948)
23 Throbbing
24 Wolff s Theory: Lack of Support Cerebral vessel dilation (by vasoactive intestinal polypeptide) does not induce migraine Induction of migraine attacks (by nitroglycerin or sildenafil) does not dilate cerebral / meningeal vessels MR angiogram during spontaneous migraine: No proximal extracranial vessel dilation 10% intracranial vessel dilation Successful sumatriptan treatment, but no intracranial vasoconstriction Schoonman et al Brain. 2008;131:2192 Kruuse et al Brain 2003;126: 241 Rahmann et al Cephalalgia 2008; 28: 226 Amin et Lancet Neurol 2013; 12:454
25 Wolff s Theory: On the other hand Many migraine drugs do not cross the blood-brain barrier (eg. sumatriptan, DHE, anti-cgrp mabs) Expression of high frequency / low risk migraine susceptibility genes is enriched in arterial tissue. Migraine shares polygenic risk with CAD and stroke. Example: PHACTR1 locus is associated with migraine, CAD, cervical artery dissection Distal external carotid diameter has not been studied with fmri during migraine attacks. Gormley et al Nat Genet. 2016; 48:856.
26 Migraine Headache PACAP Pietrobon et al Nat Rev Neurosci 4:386 (2003)
27 CGRP Roles of CGRP and PACAP in Migraine PACAP CGRP Edvinsson & Goadsby Cephalalgia 1994; 14:320 Zagami et al ACTN 2014; CGRP & PACAP are elevated in human serum during migraine CGRP CGRP & PACAP are elevated in cat serum following SSS stimulation PACAP
28 CGRP and PACAP in Migraine CGRP 37 amino acid peptide Widely expressed in neurons Infusion provokes migraine Implicated in pain, vasodilation, inflammation PACAP 38 amino acid peptide May be co-expressed with CGRP Infusion provokes migraine Implicated in pain, circadian rhythms, development, etc. Receptor antagonists block migraine
29 Trigeminovascular System: Migraine Pathways Proposed mechanisms of CSD-mediated brainstem activation, dural vasodilation, & sterile inflammation Bolay et al. Nat Med. 8:136 (2002) Zhang et al Ann Neurol. 2011;69:855 Karatas et al Science 2013;339, 1092 Tolner et al, Pain 156:S64 S74 (2015) TNC SSN
30 Serotonin in Migraine In migraine attacks, blood levels of serotonin drop and urine levels of serotonin metabolites rise. Drugs which deplete platelet serotonin (e.g. reserpine) may trigger migraine-like attacks. Intravenous serotonin relieves migraine. Serotonin is implicated in mechanisms for many conditions comorbid with migraine (e.g. depression, sleep, etc.). Anthony et al Arch Neurol 16:544 (1967) Sicuteri Headache 6:109 (1966) Kimball et al Neurol Minneap 10:107 (1960)
31 Serotonin (5-HT) Receptors and Migraine Therapies Serotonin (5HT) camp PI Na + K + Ca 2+ camp camp camp camp 5HT 1 5HT 2 5HT 3 5HT 4 5HT 5 5HT 6 5HT 7 5-HT 1A 5-HT 1B 5-HT 1D 5-HT 1E 5-HT 1F 5-HT 2A 5-HT 2B 5-HT 2C 5-HT 5A 5-HT 5B Agonists block acute migraine (e.g. triptans) Antagonists prevent migraine (e.g. methysergide) Antagonists prevent nausea (e.g. ondansetron) Adapted from: The Triptans. 2001
32 Trigeminovascular System PAIN Nucleus Caudalis CORTEX THALAMUS Superior Salivatory Nucleus D 5-HT 1D Receptors D Neuropeptide Release Trigeminal Ganglion 5-HT 1D Receptors Trigeminal Inhibition CGRP D SPG B B Vasodilatation 5-HT 1B Receptors (on vascular smooth muscle) Vasoconstriction VIP, NO Recreated from Hargreaves et al. Can J Neurol Sci 1999;26:S12-S19.
33 What Causes Hypersensitivity in Migraine? Migrain Duet - Jeanette Abulafia
34 Nervous System Sensitization in Migraine o o Dural blood vessels Cortex Thalamus Trigeminal ganglia TNC Dorsal root Ganglia (C5/6) Dorsal horn first relay
35 Photophobia in Migraine Noseda & Burstein, Pain 2013;154 Suppl 1:S44
36 Migraine Integration? Abnormal hypothalamus function?? Modified from Pietrobon, Nature Rev Neurosci. 4:386 (2003).
Faculty Disclosures. Learning Objectives
WWW.AMERICANHEADACHESOCIETY.ORG Pathophysiology Content developed by: Andrew C. Charles, MD, FAHS, Peter J. Goadsby, MD, PhD, FAHS Donna Gutterman, PharmD Faculty Disclosures ANDREW C. CHARLES, MD, FAHS
More informationA New Era of Migraine Management: The Challenging Landscape in Prevention
Provided by MediCom Worldwide, Inc. Supported by an educational grant from Teva Pharmaceuticals What is a Neuropeptide? Small chains of amino acids released by neural cells (neurons or glial cells) to
More informationGreg Book. September 25, 2007 Olin Neuropsychiatry Research Center
Migraine Pathogenesis Greg Book September 25, 2007 Olin Neuropsychiatry Research Center Migraine Migraine i affects approximately 19.2% of females and 6.6% of males in the United States. (Patel, Bigal
More informationMigraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification
28 Primary Care Medicine Principles and Practice 29 October 28 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification
More informationHEADACHE PATHOPHYSIOLOGY
HEADACHE PATHOPHYSIOLOGY Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies Director, Headache Research and Treatment
More informationPathophysiology of Migraine
Pathophysiology of Migraine 1 MIGRAINE PATHOPHYSIOLOGY: A NEUROVASCULAR HEADACHE Objectives Review the neurobiology of migraine - Features of acute attack - neuroanatomical substrates Discuss the current
More informationMigraine Controversies in Women s Health. Professor Peter J. Goadsby 5 December Department of Neurology
Migraine 2008 Controversies in Women s Health 5 December 2008 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification Primary
More informationMark W. Green, MD, FAAN
Mark W. Green, MD, FAAN Professor of Neurology, Anesthesiology, and Rehabilitation Medicine Director of Headache and Pain Medicine Icahn School of Medicine at Mt Sinai New York Pain-sensitive structures
More informationDISCLOSURES FUNCTIONS OF THE HYPOTHALAMUS
NOVEL THERAPEUTIC TARGETS: THE HYPOTHALAMUS Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies David Geffen School of
More informationACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli
The European Headache School 2012 ACUTE TREATMENT FOR MIGRAINE Cristina Tassorelli Headache Science Centre, IRCCS Neurological Institute C. Mondino Foundation - Pavia University Centre for Adaptive Disorders
More informationSupraorbital nerve stimulation Cefaly Device - FDA Approved for migraine prevention (also being investigated as acute therapy)
NEUROSTIMULATION/NEUROMODULATION UPDATE Meyer and Renee Luskin Andrew Charles, M.D. Professor Luskin Chair in Migraine and Headache Studies Director, UCLA Goldberg Migraine Program David Geffen School
More informationThe Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal
The Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal Sensitization, Central Sensitization, and Allodynia
More informationSeizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical
Are There Sharing Mechanisms of Epilepsy, Migraine and Neuropathic Pain? Chin-Wei Huang, MD, PhD Department of Neurology, NCKUH Basic mechanisms underlying seizures and epilepsy Seizure: the clinical manifestation
More informationwith susceptibility-weighted imaging and computed tomography perfusion abnormalities in diagnosis of classic migraine
Emerg Radiol (2012) 19:565 569 DOI 10.1007/s10140-012-1051-2 CASE REPORT Susceptibility-weighted imaging and computed tomography perfusion abnormalities in diagnosis of classic migraine Christopher Miller
More informationPosterior Cerebral Hypoperfusion in Migraine without Aura Marie Denuelle, MD Neurology Service, Rangueil Hospital Toulouse, France
Posterior Cerebral Hypoperfusion in Migraine without Aura Marie Denuelle, MD Neurology Service, Rangueil Hospital Toulouse, France Most of the cerebral blood flow (CBF) studies in migraine have introduced
More informationClinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.
OVERVIEW Refractory headaches and update on novel treatment Definition of refractory headache Treatment approach Medications Neuromodulation In the pipeline Juliette Preston, MD OHSU Headache Center Refractory
More informationDISCLOSURES UPDATE ON MIGRAINE EPIDEMIOLOGY, GENETICS, AND BASIC MECHANISMS. Grant Support Takeda
UPDATE ON MIGRAINE EPIDEMIOLOGY, GENETICS, AND BASIC MECHANISMS Andrew Charles, M.D. Professor of Neurology Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache
More informationThe main features of the TACs:
Pathophysiology of trigeminal autonomic cephalalgias Jasna Zidverc Trajković Headache center The main features of the TACs: 1. Trigeminal distribution of the pain 2. Ipsilateral cranial autonomic features
More informationPathophysiology of Headache Past and Present
Headache ISSN 0017-8748 C 2007 the Author doi: 10.1111/j.1526-4610.2007.00678.x Journal compilation C 2007 American Headache Society Published by Blackwell Publishing Pathophysiology of Headache Past and
More informationThe PACAP Receptor: A Novel Target for Migraine Treatment
DEPARTMENT OF NEUROLOGY D A N I& S DANISH H H E AHEADACHE D A C H E CENTER C E N T E R Faculty of Health and Medical Sciences The PACAP Receptor: A Novel Target for Migraine Treatment Messoud Ashina, MD,
More informationDefective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine type 2
Defective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine type 2 Daniela Pietrobon Dept. of Biomedical Sciences, University of Padova CNR Institute of Neuroscience Migraine
More informationMIGRAINE A CAUSE OF INTENSE THROBBING; A MINI REVIEW
IJBPAS, January, 2016, 5(1): 87-92 ISSN: 2277 4998 MIGRAINE A CAUSE OF INTENSE THROBBING; A MINI REVIEW MUHAMMAD ZAMAN 1*, RABIA HASSAN 1, MUHAMMAD SHAFEEQ UR RAHMAN 2, MUHAMMAD HAFIZ ARSHAD 3, SYED ATIF
More informationMIGRAINES RESEARCH PRESENTATION ONE
MIGRAINES RESEARCH PRESENTATION ONE GROUP 4 Miguel Cardoso, Shara Chowdhury, Sabrina Musto, Harpreet Pabla, Ojan Yarkhani. LIFESCI 4M03 Research Seminar Instructor Dr. Daniel Yang 1 EPIDEMIOLOGY The incidence,
More informationChapter 2 Anatomy and Pathophysiology of Migraine
Chapter 2 Anatomy and Pathophysiology of Migraine Stewart J. Tepper Introduction The anatomy and the pathways in the pathophysiology of migraine, while extensively explored in the past several decades,
More informationCGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS)
CGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS) Hans-Christoph Diener Senior Professor of Clinical Neurosciences University Duisburg-Essen Germany CGRP, Monoclonal Antibodies and Small Molecules
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: November 30, 2018 Zomig Description Zomig / Zomig-ZMT
More informationMigraine - whats on the horizon
Managing your migraine Edinburgh Saturday 10 th March 2018 Migraine - whats on the horizon Alok Tyagi Consultant Neurologist Glasgow Disclaimer I have received from Janssen Cillag, GSK, Allergan, Electrocore,
More informationAdvances in the Treatment of Migraine
Advances in the Treatment of Migraine C. Philip O Carroll, M.D. Director Neurobehavioral Medicine Hoag Neurosciences Institute Guyuron B Headache, 2015;55:1464-1473 I m sorry your head hurts, sweetie.is
More informationThe Role of Allergies and Sinus Disorders in Headache & Facial Pain
The Role of Allergies and Sinus Disorders in Headache & Facial Pain Vincent T. Martin, MD Professor of Medicine Co-director of the Headache & Facial Pain Center University of Cincinnati College of Medicine
More informationMigraine and hormonal contraceptives
Migraine and hormonal contraceptives Department of Community Medicine, Systems Epidemiology University of Tromsø, November 2017 Nora Stensland Bugge Medical research student Presentation outline What is
More informationCase Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches
Agenda Case presentation Migraine Morphology Primary and Premonitory Phase Secondary Headache Aura Headache Primer on Pain Medication Overuse Headache Case Presentation RT is a 25 year old woman with daily
More informationADVANCES IN MIGRAINE MANAGEMENT
ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades
More informationONZETRA XSAIL (sumatriptan) nasal powder
ONZETRA XSAIL (sumatriptan) nasal powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationEmbriologically, The head is formed from the first two cervical segments (except the mandible, which is formed by the third). The first and second
Embriologically, The head is formed from the first two cervical segments (except the mandible, which is formed by the third). The first and second cervical vertebra are also derived from these two segments.
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: March 16, 2018 Zomig Description Zomig / Zomig-ZMT
More informationStructures Related with Headache
PATHOPHYSIOLOGY Structures Related with Headache 2 Primary vs. Secondary Headache Primary Headache Not a symptom of or caused by another disease or condidon Secondary Headache A symptom of or caused by
More informationMIGRAINE A MYSTERY HEADACHE
MIGRAINE A MYSTERY HEADACHE The migraine is a chronic neurological disease that is characterized by moderate to severe episodes of headache that is mostly associated with other central nervous system (CNS)
More informationMigraine Research Update Clinical and Scientific Highlights. David W. Dodick M.D. Professor Department of Neurology Mayo Clinic Phoenix Arizona
Migraine Research Update Clinical and Scientific Highlights David W. Dodick M.D. Professor Department of Neurology Mayo Clinic Phoenix Arizona 1 Objective Discuss some of the important advances in clinical
More informationStudy of sleep and evaluation of sumatriptan and rizatriptan in the acute treatment of migraine in children and adolescents
Department of Child Neurology Department of Clinical Pharmacology University of Helsinki Finland Study of sleep and evaluation of sumatriptan and rizatriptan in the acute treatment of migraine in children
More informationThe Molecular Mechanism of Migraine
Brigham Young University BYU ScholarsArchive All Theses and Dissertations 2011-07-06 The Molecular Mechanism of Migraine Kristin Dawn Watson Brigham Young University - Provo Follow this and additional
More informationGeneral Sensory Pathways of the Face Area, Taste Pathways and Hearing Pathways
General Sensory Pathways of the Face Area, Taste Pathways and Hearing Pathways Lecture Objectives Describe pathways for general sensations (pain, temperature, touch and proprioception) from the face area.
More informationSandler Family Trust. UCSF Medical Center. Headache A Review and Update. Headache The burden. Headache Group, UCSF Disclosure- by proportion*
1 Headache A Review and Update Advances in Internal Medicine June 29 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Headache Group, UCSF Disclosure- by proportion Sandler Family Trust UCSF
More informationSUMAVEL DOSEPRO (sumatriptan succinate) solution for injection
SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit
More informationFamilial hemiplegic migraine
PHD THESIS DANISH MEDICAL BULLETIN Familial hemiplegic migraine An experimental genetic headache model Jakob Møller Hansen, MD This review has been accepted as a thesis together with four previously published
More informationSpecific Objectives A. Topics to be lectured and discussed at the plenary sessions
Specific Objectives A. Topics to be lectured and discussed at the plenary sessions 0. Introduction: Good morning ICHD-III! Let s start at the very beginning. When you read you begin with A-B-C, so when
More informationSumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 0 Subject: Sumatriptan Page: 1 of 6 Last Review Date: November 30, 2018 Sumatriptan Description Sumatriptan
More informationMigraine Treatment What you need to know
Migraine Treatment What you need to know DR NICOLE LIMBERG ST ANDREWS PLACE SPRING HILL www.migrainespecialist.com.au Migraine what is it? Primary neurobiological condition Waves of reduced brain activity
More informationDifferentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD
Differentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD University of California, San Francisco San Francisco, CA King's College London London, England Learning
More informationUCSF Neurology a welcoming place! Migraine Headache clinical classification. Secondary infection hemorrhage trauma tumour CSF pressure change
28 UCSF Neurology a welcoming place! Recent Advances in Neurology Ritz-Carlton Hotel, San Francisco 13 February 28 Professor Peter J. Goadsby Department of Neurology Headache clinical classification Age
More informationTears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE
Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal
More informationMigraine Management. Roger Cady, MD Headache Care Center Springfield, MO
Migraine Management Roger Cady, MD Headache Care Center Springfield, MO Disclosures Objectives The evolution of migraine From benign episodic (benign) headache to potentially a devastating chronic disease
More informationAn Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California
An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect
More informationWhat is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary
What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary Overview Understanding the burden Commonly used terms Acute therapy What we currently have What we are going
More informationHeadache Assessment In Primary Eye Care
Headache Assessment In Primary Eye Care Spencer Johnson, O.D., F.A.A.O. Northeastern State University Oklahoma College of Optometry johns137@nsuok.edu Course Objectives Review headache classification Understand
More informationDisruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B 1D receptor agonists
Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B 1D receptor agonists Dan Levy*, Moshe Jakubowski*, and Rami Burstein* *Departments
More informationHeadache A Practical Approach
Headache A Practical Approach Integrated Pain Symposium December 1, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache and Pain Development Teams Disclosures:
More informationUniversity of Groningen. Modelling trigeminovascular pain in the unrestrained rat Kemper, Richard Hendrikus Antonius
University of Groningen Modelling trigeminovascular pain in the unrestrained rat Kemper, Richard Hendrikus Antonius IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF)
More information211MDS Pain theories
211MDS Pain theories Definition In 1986, the International Association for the Study of Pain (IASP) defined pain as a sensory and emotional experience associated with real or potential injuries, or described
More informationChapter 17. Nervous System Nervous systems receive sensory input, interpret it, and send out appropriate commands. !
Chapter 17 Sensory receptor Sensory input Integration Nervous System Motor output Brain and spinal cord Effector cells Peripheral nervous system (PNS) Central nervous system (CNS) 28.1 Nervous systems
More informationSeeking the best care for acute migraine
J Headache Pain (2002) 3:1 5 Springer-Verlag 2002 EDITORIAL Marcello Fanciullacci Seeking the best care for acute migraine M. Fanciullacci ( ) Headache Center, Department of Internal Medicine, University
More informationMigraine pathophysiology: lessons from mouse models and human genetics
Migraine pathophysiology: lessons from mouse models and human genetics Michel D Ferrari, Roselin R Klever, Gisela M Terwindt, Cenk Ayata, Arn M J M van den Maagdenberg Migraine is a common, disabling,
More informationPATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Physiol Rev 97: 553 622, 2017 Published February 8, 2017; doi:10.1152/physrev.00034.2015 PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING Peter J. Goadsby, Philip R. Holland, Margarida Martins-Oliveira,
More informationSumatriptan Injection (Imitrex / Alsuma / Sumavel / Zembrace)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.11 Subject: Sumatriptan Injection Page: 1 of 6 Last Review Date: March 16, 2018 Sumatriptan Injection
More informationSumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 05.70.10 Subject: Sumatriptan Page: 1 of 6 Last Review Date: March 16, 2018 Sumatriptan Description Sumatriptan
More informationHeadache Pain Generators
Objectives 1. Define the major categories of headache. 2. Take a history directed at characterizing a headache pattern in an individual patient and identify the cause or triggers of the headache. 3. Understand
More informationMigraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015
1 Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin Tour de France 2015: Mark Renshaw Yesterday at the end of the stage 17 I came down with a migraine before the final climb
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More informationUpdate on Diagnosis and Management of Migraines
Update on Diagnosis and Management of Migraines Joel J. Heidelbaugh, MD, FAAFP, FACG Clinical Professor Departments of Family Medicine and Urology University of Michigan Learning Objectives To distinguish
More information10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD
Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD } Depomed Consultant 2014 to present } Avanir Consultant 2014 to present } Amgen
More informationOCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA
OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition Joint Session with ACOFP, ACONP and AOAAM:
More informationMIGRAINE CLASSIFICATION
MIGRAINE CLASSIFICATION Nada Šternić At most, only 30% of migraineurs have classic aura The same patient may have migraine headache without aura, migraine headache with aura as well as migraine aura without
More informationComparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine
Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology July 2006 Comparison of dynamic (brush) and static (pressure) mechanical allodynia in
More informationDisclosures. Objectives 6/2/2017
Classification: Migraine and Trigeminal Autonomic Cephalalgias Lauren Doyle Strauss, DO, FAHS Assistant Professor, Child Neurology Assistant Director, Child Neurology Residency @StraussHeadache No disclosures
More informationAuditory Brainstem Evoked Responses In Migraine Patients
ISPUB.COM The Internet Journal of Neurology Volume 12 Number 1 Auditory Brainstem Evoked Responses In Migraine Patients D Kaushal, S Sanjay Munjal, M Modi, N Panda Citation D Kaushal, S Sanjay Munjal,
More informationEmerging drugs for migraine treatment: an update
Expert Opinion on Emerging Drugs ISSN: 1472-8214 (Print) 1744-7623 (Online) Journal homepage: http://www.tandfonline.com/loi/iemd20 Emerging drugs for migraine : an update Giorgio Lambru, Anna P. Andreou,
More informationControlling Migraine Pain
Migraine Stats Controlling Migraine Pain Alan Zacharias, M.D. Associated Neurologists, Boulder Community Health 303-622-3365 Women 15% Men 5% Usually starts in 2 nd and 3 rd Decade Major Impact on days
More informationISSN doi: /head VC 2017 American Headache Society Published by Wiley Periodicals, Inc.
ISSN 0017-8748 Headache doi: 10.1111/head.13081 VC 2017 American Headache Society Published by Wiley Periodicals, Inc. Supplement Article The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors
More informationBedside to bench and back Challenging Conventional Wisdom, Migraine
Bedside to bench and back Challenging Conventional Wisdom, Migraine Lecture handout for Association for Research In Otolaryngology Meeting in Phoenix, Feb 16, 2008 Timothy C. Hain, MD, Chicago IL. Definition
More informationClinical Learning Days November 10, 2017
Migraine Clinical Learning Days November 10, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache Disclosures: none Learning Objectives: At the conclusion
More informationThe Role of TRP Channels in Migraine
The Role of TRP Channels in Migraine Gerry Stephen Oxford 1 and Joyce Harts Hurley*,2 Send Orders of Reprints at reprints@benthamscience.net The Open Pain Journal, 2013, 6, (Suppl 1: M6) 37-49 37 Open
More informationlecture #2 Done by : Tyma'a Al-zaben
lecture #2 Done by : Tyma'a Al-zaben ** Hello SERTONIN! note:: the slide included within the sheet but make sure back to slide for pictures in the previous lecture we talk about ascending tract and its
More information2) Headache - Dr. Hawar
2) Headache - Dr. Hawar Headache is caused by traction, displacement, inflammation, vascular spasm, or distention of the painsensitive structures in the head or neck. Isolated involvement of the bony skull,
More informationDennis Mathews, O.D. Partner, ESG Board Certified, ABO
Dennis Mathews, O.D. Partner, ESG Board Certified, ABO Define migraine disorders Signs and symptoms of migraine disorders Differential diagnosis Management A JOKE!!! Sensory neurons from trigeminal ganglion
More informationASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION
Acta Medica Mediterranea, 2014, 30: 1007 ASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION E. ESRA OKUYUCU*, OGUZ GUVEN**, EDIP UCAR***, TASKIN DUMAN*
More informationThe Clinical Profile of Sumatriptan: Cluster Headache Key Words
Paper Eur Neurol 1994;34(suppl 2):35-39 P.J. Peter J. Goadsby Department of Neurology, The Prince Henry Hospital, Little Bay, Sydney, NSW, Australia The Clinical Profile of Sumatriptan: Cluster Headache
More informationReview of frovatriptan in the treatment of migraine
EXPERT OPINION Review of frovatriptan in the treatment of migraine Leslie Kelman Headache Center of Atlanta, Atlanta, GA, USA Abstract: Triptans are recommended for the acute treatment of moderate to severe
More informationViews and Perspectives
Headache 2011 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2011.01844.x Published by Wiley Periodicals, Inc. Views and Perspectives The Extracranial Vascular Theory of Migraine A Great
More informationMigraine: Diagnosis and Therapeutic Advances
#50070 Migraine: Diagnosis and Therapeutic Advances COURSE #50070 5 CREDIT HOURS Release Date: 07/01/15 Expiration Date: 06/30/18 Migraine: Diagnosis and Therapeutic Advances HOW TO RECEIVE CREDIT Read
More informationMechanisms of Headache in Intracranial Hypotension
Mechanisms of Headache in Intracranial Hypotension Stephen D Silberstein, MD Jefferson Headache Center Thomas Jefferson University Hospital Philadelphia, PA Stephen D. Silberstein, MD, FACP Director, Jefferson
More informationUNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition
UNDERSTANDING CHRONIC MIGRAINE Learn about diagnosis, management, and treatment options for this headache condition 1 What We re Going to Cover Today The symptoms and phases of migraine Differences between
More informationHEADACHES THE RED FLAGS
HEADACHES THE RED FLAGS FAYYAZ AHMED CONSULTANT NEUROLOGIST HON. SENIOR LECTURER HULL YORK MEDICAL SCHOOL SECONDARY VS PRIMARY HEADACHES COMMON SECONDARY HEADACHES UNCOMMON BUT SERIOUS SECONDARY HEADACHES
More informationIs Migraine a Neuropathic Pain Syndrome?
Is Migraine a Neuropathic Pain Syndrome? David M. Biondi, DO Corresponding author David M. Biondi, DO Headache Management Program, Spaulding Rehabilitation Hospital, 125 Nashua Street, Boston, MA 02114,
More informationMigraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital
Migraine Management Jane Melling Headache nurse Mater Misericordiae Hospital Migraine facts Among the most common disorders of the nervous system 3 rd most prevalent medical disorder on the planet (lancet
More informationMigraine is a common disabling condition in people
Review J Vet Intern Med 2013;27:1034 1040 Migraine-like Episodic Pain Behavior in a Dog: Can Dogs Suffer from Migraines? I.N. Plessas, H.A. Volk, and P.J. Kenny Migraines and other primary headache disorders
More informationThe prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
Blackwell Publishing LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 20062006261012091213Original ArticleThe prevalence of premonitory symptoms in migrainegg Schoonman et al. The prevalence of premonitory
More informationNsci 2100: Human Neuroanatomy Examination 1
Name KEY Lab Section Nsci 2100: Human Neuroanatomy Examination 1 On this page, write your name and lab section. On your scantron answer sheet, enter your name (last name, space, first name), internet ID
More informationNitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels
British Journal of Pharmacology (2002) 137, 62 ± 68 ã 2002 Nature Publishing Group All rights reserved 0007 ± 1188/02 $25.00 www.nature.com/bjp Nitric oxide synthase inhibitors can antagonize neurogenic
More informationNeurobiology in primary headaches
Brain Research Reviews 48 (2005) 438 456 Review Neurobiology in primary headaches www.elsevier.com/locate/brainresrev Lars Edvinsson a, *, Rolf Uddman b a Department of Internal Medicine, University Hospital,
More informationChapter Fifteen. Neurological Disorders
Chapter Fifteen Neurological Disorders Causes of Neurological Disorders Head Injuries Tumors Seizures Drugs (primary effects, side effects, and withdrawal) Circulation Issues Circulation Issues STROKES!
More informationSymptoms. What/Where, When, How Long
Cluster Headaches Symptoms What/Where, When, How Long *Symptoms include: *Unilateral pain in head (one sided) *Typically centred over one eye, temple or forehead but can spread to a larger area. *Difficulty
More information